EYE vs SOM

ASX Healthcare sector comparison — updated 3 Sep 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

58MEDIUM

SOM

SOMNOMED FPO [SOM]

55MEDIUM

Score Breakdown

EYE SOM
Technical
46
59
Catalyst
54
55
Sentiment
50
50
Fundamental
60
86
Momentum
65
36
Risk Gate
50
45

Key Metrics

EYE Metric SOM
$38.5MMarket Cap$75.8M
199KAvg Volume (20d)59K
N/AShort InterestN/A
$0.20552-Week High$0.945
$0.10052-Week Low$0.300
+3.8%Daily Change-2.8%
$0.135Reference Price$0.345
-26.1%ROE-5.7%
-12.4%Profit Margin-2.3%

Active Signals

EYE Signals

●Stochastic just turned bullish from a low level — early reversal sign
●Lagging the Small Ords index — relative strength of 0.89, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.2 quarters)
●Low P/S ratio (1.1x)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

SOM Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.7x)
●Revenue declining (-7%)

Ask Scout AI to compare EYE and SOM in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NOX vs RHT →LDX vs SPL →BLS vs SPL →ATX vs SPL →BLS vs LDX →
EYE Full Analysis → SOM Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).